ALLOPLEX BIOTHERAPEUTICS

Alloplex Biotherapeutics is a privately held Boston based cellular therapeutics company. Their lead oncology therapeutic is a PBMC-derived multicellular adoptive immunotherapy which they call SUPLEXA cells. They use proprietary leukocyte activator cell lines (ENLiST cells), which are engineered from a common tumor cell line to express an array of immunomodulatory ligands designed to specifically engage and activate various subsets of peripheral blood mononuclear cells (PBMC) through their native... receptors. Alloplex has developed SUPLEXA cells through the use of an all-human in vitro assay which not only models the intended ex vivo activation of patient PBMC but is, in fact, the actual procedure to be deployed in the clinic. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

ALLOPLEX BIOTHERAPEUTICS

Social Links:

Industry:

Biopharma Biotechnology Health Care

Founded:

2016-01-01

Address:

Boston, Massachusetts, United States

Country:

United States

Website Url:

http://www.alloplexbio.com

Total Employee:

Status:

Active

Total Funding:

1.2 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics